CoChat

A clinical perspective of obesity, metabolic syndrome and cardiovascular disease

Open access
Han, Thang S, Lean, Mike EJ · 2016 · JRSM Cardiovascular Disease

The DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.

Abstract

The metabolic syndrome is a condition characterized by a special constellation of reversible major risk factors for cardiovascular disease and type 2 diabetes. The main, diagnostic, components are reduced HDL-cholesterol, raised triglycerides, blood pressure and fasting plasma glucose, all of which are related to weight gain, specifically intra-abdominal/ectopic fat accumulation and a large waist circumference. Using internationally adopted arbitrary cut-off values for waist circumference, having metabolic syndrome doubles the risk of cardiovascular disease, but offers an effective treatment approach through weight management. Metabolic syndrome now affects 30–40% of people by age 65, driven mainly by adult weight gain, and by a genetic or epigenetic predisposition to intra-abdominal/ectopic fat accumulation related to poor intra-uterine growth. Metabolic syndrome is also promoted by a lack of subcutaneous adipose tissue, low skeletal muscle mass and anti-retroviral drugs. Reducing weight by 5–10%, by diet and exercise, with or without, anti-obesity drugs, substantially lowers all metabolic syndrome components, and risk of type 2 diabetes and cardiovascular disease. Other cardiovascular disease risk factors such as smoking should be corrected as a priority. Anti-diabetic agents which improve insulin resistance and reduce blood pressure, lipids and weight should be preferred for diabetic patients with metabolic syndrome. Bariatric surgery offers an alternative treatment for those with BMI ≥ 40 or 35–40 kg/m 2 with other significant co-morbidity. The prevalence of the metabolic syndrome and cardiovascular disease is expected to rise along with the global obesity epidemic: greater emphasis should be given to effective early weight-management to reduce risk in pre-symptomatic individuals with large waists.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2048004016633371

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 101 references

Research works printed but not linked: 6

  1. Bouchard C, 1995, Int J Obes, 19, S52
  2. Han TS, 1995, Proc Nutr Soc, 54, 182A
  3. Kelly IE, 2001, Diabetes Care, 24, 683, 10.2337/diacare.24.4.683 · DOI · Paper page
  4. 10.1001/archinte.1989.00390070054005 · DOI · Paper page
  5. Greenfield DM, 2015, Clin Endocrinol (Oxf)
  6. Department of Health. Alcohol Guidelines Review – Report from the Guidelines development group to the UK Chief Medical Officers, January 2016. Produced by William Lea for the Department of Health.

Cited by

See all 550

Metadata

Authors
Han, T. S., & Lean, M. E.
Affiliations
  • Royal Holloway University of London (GB)
  • Human Nutrition, School of Medicine, University of Glasgow, UK
Corresponding author
Han, Thang S
Venue
JRSM Cardiovascular Disease
Published
2016-01-01
Volume
5
Pages
2048004016633371-2048004016633371
ISSN
2048-0040 (ISSN-L)
OpenAlex
W2311898277
Cited by
500
References
102
Citations by year
2026: 15 · 2025: 38 · 2024: 51 · 2023: 46 · 2022: 55 · 2021: 67 · 2020: 71 · 2019: 50 · 2018: 52 · 2017: 43 · 2016: 10
FWCI
7.60
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • JRSM Cardiovascular Disease (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
metabolic syndrome, obesity, cardiovascular disease, type 2 diabetes, waist circumference, intra-abdominal fat, ectopic fat, weight management, anti-obesity drugs, bariatric surgery, insulin resistance, antidiabetic drugs, smoking, subcutaneous adipose tissue, skeletal muscle mass, antiretroviral drugs, fetal growth restriction, diet and exercise

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. https://app.cochat.ai/papers/10.1177/2048004016633371
The paper
Han, T. S., & Lean, M. E. (2016). A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovascular Disease. https://doi.org/10.1177/2048004016633371

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.